US Stock MarketDetailed Quotes

NIVF NewGenIvf

Watchlist
  • 1.370
  • +0.140+11.38%
Close May 31 16:00 ET
  • 1.350
  • -0.020-1.46%
Post 19:46 ET
11.35MMarket Cap-2978P/E (TTM)

NewGenIvf Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2022
(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
19.39%1.71M
1.43M
Net income from continuing operations
198.06%135.85K
---138.53K
Operating gains losses
--114.01K
----
Depreciation and amortization
-11.27%303.94K
--342.54K
Other non cash items
20.00%240K
--200K
Change In working capital
-11.34%906.32K
--1.02M
-Change in receivables
70.80%114.73K
--67.17K
-Change in inventory
-633.95%-7.22K
--1.35K
-Change in payables and accrued expense
43.80%445.41K
--309.75K
-Change in other current liabilities
-15.73%-194.61K
---168.15K
-Change in other working capital
-32.52%548.01K
--812.16K
Cash from discontinued investing activities
Operating cash flow
19.39%1.71M
--1.43M
Investing cash flow
Cash flow from continuing investing activities
-469.85%-94.45K
-16.58K
Net PPE purchase and sale
-469.85%-94.45K
---16.58K
Cash from discontinued investing activities
Investing cash flow
-469.85%-94.45K
---16.58K
Financing cash flow
Cash flow from continuing financing activities
-5.79%-1.63M
-1.54M
Net issuance payments of debt
-78.06%108.73K
--495.6K
Net other financing activities
14.58%-1.74M
---2.04M
Cash from discontinued financing activities
Financing cash flow
-5.79%-1.63M
---1.54M
Net cash flow
Beginning cash position
-72.91%28.76K
--106.19K
Current changes in cash
86.45%-17.33K
---127.94K
Effect of exchange rate changes
-68.08%16.12K
--50.51K
End cash Position
-4.20%27.56K
--28.76K
Free cash flow
14.12%1.62M
--1.42M
Currency Unit
USD
USD
(FY)Dec 31, 2022(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 19.39%1.71M1.43M
Net income from continuing operations 198.06%135.85K---138.53K
Operating gains losses --114.01K----
Depreciation and amortization -11.27%303.94K--342.54K
Other non cash items 20.00%240K--200K
Change In working capital -11.34%906.32K--1.02M
-Change in receivables 70.80%114.73K--67.17K
-Change in inventory -633.95%-7.22K--1.35K
-Change in payables and accrued expense 43.80%445.41K--309.75K
-Change in other current liabilities -15.73%-194.61K---168.15K
-Change in other working capital -32.52%548.01K--812.16K
Cash from discontinued investing activities
Operating cash flow 19.39%1.71M--1.43M
Investing cash flow
Cash flow from continuing investing activities -469.85%-94.45K-16.58K
Net PPE purchase and sale -469.85%-94.45K---16.58K
Cash from discontinued investing activities
Investing cash flow -469.85%-94.45K---16.58K
Financing cash flow
Cash flow from continuing financing activities -5.79%-1.63M-1.54M
Net issuance payments of debt -78.06%108.73K--495.6K
Net other financing activities 14.58%-1.74M---2.04M
Cash from discontinued financing activities
Financing cash flow -5.79%-1.63M---1.54M
Net cash flow
Beginning cash position -72.91%28.76K--106.19K
Current changes in cash 86.45%-17.33K---127.94K
Effect of exchange rate changes -68.08%16.12K--50.51K
End cash Position -4.20%27.56K--28.76K
Free cash flow 14.12%1.62M--1.42M
Currency Unit USDUSD

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg